PTC Therapeutics, Inc. - Common Stock (PTCT)
45.88
-0.27 (-0.59%)
PTC Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapies for the treatment of rare diseases and cancer
The company specializes in the development of small molecules and gene therapies that target underlying genetic causes of diseases. PTC Therapeutics aims to advance its proprietary drug candidates through clinical trials, leveraging its unique expertise in RNA biology and translational medicine. By utilizing cutting-edge technology and a collaborative approach, the company strives to bring transformative treatments to patients with unmet medical needs.
Frequently Asked Questions
Is PTC Therapeutics, Inc. - Common Stock publicly traded?
Yes, PTC Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does PTC Therapeutics, Inc. - Common Stock trade on?
PTC Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PTC Therapeutics, Inc. - Common Stock?
The ticker symbol for PTC Therapeutics, Inc. - Common Stock is PTCT on the Nasdaq Stock Market
What is the current price of PTC Therapeutics, Inc. - Common Stock?
The current price of PTC Therapeutics, Inc. - Common Stock is 45.88
When was PTC Therapeutics, Inc. - Common Stock last traded?
The last trade of PTC Therapeutics, Inc. - Common Stock was at 4:15 pm EST on January 31st, 2025
What is the market capitalization of PTC Therapeutics, Inc. - Common Stock?
The market capitalization of PTC Therapeutics, Inc. - Common Stock is 3.54B
How many shares of PTC Therapeutics, Inc. - Common Stock are outstanding?
PTC Therapeutics, Inc. - Common Stock has 77.13M shares outstanding.